Login| Sign Up| Help| Contact|

Patent Searching and Data

Document Type and Number:
Japanese Patent JPH09507248
Kind Code:
This invention is directed to novel purine-based compounds for inclusion into oligonucleotides. The compounds of the invention, when incorporated into oligonucleotides are especially useful as "antisense" agents-agents that are capable of specific hybridization with a nucleotide sequence of an RNA. The compounds of the invention may also be used for cross-linking oligonucleotides. Oligonucleotides are used for a variety of therapeutic and diagnostic purposes, such as treating diseases, regulating gene expression in experimental systems, assaying for RNA and for RNA products through the employment of antisense interactions with such RNA, diagnosing diseases, modulating the production of proteins, and cleaving RNA in site specific fashions. The compounds of the invention include novel heterocyclic bases, nucleosides, and nucleotides. When incorporated into oligonucleotides, the compounds of the invention can be useful for modulating the activity of RNA.

Application Number:
Publication Date:
July 22, 1997
Filing Date:
February 01, 1995
Export Citation:
Click for automatic bibliography generation   Help
International Classes:
A61K31/70; A01N25/02; A01N43/52; A61K31/38; A61K31/4178; A61K31/7042; A61K31/7052; A61K31/7056; A61K31/706; A61K31/7064; A61K31/7068; A61K31/7072; A61K31/7076; A61K31/708; A61K31/7088; A61K48/00; A61P31/04; A61P31/12; A61P43/00; C07D409/12; C07D473/04; C07D473/16; C07D473/40; C07D487/04; C07H19/00; C07H19/04; C07H19/052; C07H19/056; C07H19/06; C07H19/10; C07H19/12; C07H19/14; C07H19/16; C07H19/167; C07H19/173; C07H19/19; C07H19/20; C07H19/23; C07H21/00; C07H21/02; C07H21/04; C07H23/00; C07J43/00; C07K14/16; C12N9/02; C12N15/09; C12N15/113; C12P21/00; C12Q1/68; C12Q1/6813; C12Q1/70; A61K38/00; (IPC1-7): C07D473/16; A61K31/70; C07D473/04; C07D473/40; C07D487/04; C07H19/14; C07H19/16; C07H19/167; C07H19/173; C07H21/02; C07H21/04; C12N15/09
Attorney, Agent or Firm:
湯浅 恭三 (外6名)